DoW Breast Cancer, Transformative Breast Cancer Consortium Development Award

The Department of the Army’s USAMRAA is offering the FY26 Breast Cancer Research Program Transformative Breast Cancer Consortium Development Award, a cooperative agreement intended to give investigators and breast cancer consumer advocates time and resources to build a consortium framework for a future full consortium award. The work supports establishing the consortium structure and conducting preliminary research, with the Principal Investigator serving as Consortium Director and consumer advocates actively participating in development and execution. Applications must address at least one FY26 BCRP overarching challenge or justify an exception, and the opportunity emphasizes consortium impact, team composition, structure, integration, and preliminary research; clinical trials are not allowed. The program provides approximately $140,000 for one award, and applications are due July 8, 2026, through eBRAP, with pre-application and full-application steps also routed through eBRAP or Grants.gov. For questions, the listed help desk is available at 301-682-5507 and help@eBRAP.org.